Germany
Japan
United Kingdom
China
Fluorescent Protein Antibodies
Download
Active filters
Category
- Antibodies
Antibody Hosts
- Mouse
Filter by
Target Symbol
- CD68 (126)
- PTPRC (103)
- CD44 (84)
- CD33 (80)
- CD19 (78)
- KIT (71)
- NCAM1 (70)
- CD163 (64)
- CD34 (62)
- FCGR2A (62)
- CD22 (53)
- CD38 (45)
- MME (38)
- CD3E (35)
- FCGR3A (26)
- IL3RA (22)
- CD7 (17)
- ITGB3 (15)
- ITGAM (12)
- FLT3 (5)
- ITGA2B (5)
- KLRD1 (5)
- LTBR (5)
- CD55 (3)
- ITGA3 (3)
- ITGB2 (3)
- FCGR2B (2)
- ITGA4 (2)
- ITGAX (2)
- CALD1 (1)
- CCR3 (1)
- CD10 (1)
- CD16 (1)
- CD247 (1)
- GYPA (1)
- ITGA5 (1)
- ITGA6 (1)
Reactivities
Applications
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Transmembrane (1029)
- Druggable Genome (920)
- ES Cell Differentiation/IPS (523)
- Adult stem cells (213)
- Embryonic stem cells (213)
- Cancer stem cells (169)
- Phosphatase (97)
- Secreted Protein (87)
- Stem cell relevant signaling - DSL/Notch pathway (84)
- Protein Kinase (75)
- Stem cell - Pluripotency (70)
- Protease (35)
- Induced pluripotent stem cells (26)
Pathways
- Hematopoietic cell lineage (580)
- Cell adhesion molecules (CAMs) (290)
- Primary immunodeficiency (199)
- Fc gamma R-mediated phagocytosis (183)
- T cell receptor signaling pathway (127)
- B cell receptor signaling pathway (126)
- Lysosome (125)
- ECM-receptor interaction (104)
- Cytokine-cytokine receptor interaction (100)
- Systemic lupus erythematosus (86)
- Pathways in cancer (80)
- Acute myeloid leukemia (75)
- Endocytosis (70)
- Melanogenesis (70)
- Prion diseases (68)
- Alzheimer's disease (35)
- Renin-angiotensin system (35)
- Regulation of actin cytoskeleton (33)
- Natural killer cell mediated cytotoxicity (32)
- Calcium signaling pathway (26)
- Metabolic pathways (26)
- Nicotinate and nicotinamide metabolism (26)
- Apoptosis (20)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (20)
- Dilated cardiomyopathy (20)
- Focal adhesion (20)
- Hypertrophic cardiomyopathy (HCM) (20)
- Jak-STAT signaling pathway (20)
- Leukocyte transendothelial migration (12)
- Antigen processing and presentation (5)
- Graft-versus-host disease (5)
- Small cell lung cancer (5)
- Viral myocarditis (3)
- Complement and coagulation cascades (2)
- Vascular smooth muscle contraction (1)